Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ABIO ARCA Biopharma Inc

3,36

0,07 (2,13%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:07:19

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more ARCA Biopharma Charts.

ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more ARCA Biopharma Charts.

News ARCA Biopharma Inc

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
Donnerstag 25 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
Freitag 5 April 2024 (1 Monat vor) • PR Newswire (US)

ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
Mittwoch 3 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 7 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 1 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

ARCA biopharma Announces 2023 Financial Results
Donnerstag 1 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Donnerstag 1 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 1 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 31 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 31 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 31 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere ARCA Biopharma Inc News-Artikel

Deutsche Telekom (QX)

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen